MICHELLE STREB: Open Payments
NPI 1861897688 · GRANGER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 24 payments from 11 companies in 2025. Trend: 2023 $510 · 2024 $329 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $99 |
| ABBVIE INC. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Lundbeck LLC | 2 | $45 |
| Novo Nordisk Inc | 2 | $35 |
| PFIZER INC. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $20 |
| Insulet Corporation | 1 | $18 |
Products named: JARDIANCE, VRAYLAR, REXULTI, MOUNJARO, AIRSUPRA, Kerendia, Ozempic, FREESTYLE LIBRE 3.
Industry payments across IN — which companies pay providers there.
